Characterization of fimasartan metabolites in human liver microsomes and human plasma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Ji-Yoon | - |
dc.contributor.author | Choi, Young Jae | - |
dc.contributor.author | Oh, Soo Jin | - |
dc.contributor.author | Chi, Yong Ha | - |
dc.contributor.author | Paik, Soo Heui | - |
dc.contributor.author | Lee, Ki Ho | - |
dc.contributor.author | Jung, Jae-Kyung | - |
dc.contributor.author | Ryu, Chang Seon | - |
dc.contributor.author | Kim, Kwon-Bok | - |
dc.contributor.author | Kim, Dong-Hyun | - |
dc.contributor.author | Yoon, Young-Ran | - |
dc.contributor.author | Kim, Sang Kyum | - |
dc.date.accessioned | 2021-09-04T04:13:26Z | - |
dc.date.available | 2021-09-04T04:13:26Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2016-01-02 | - |
dc.identifier.issn | 0049-8254 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/89843 | - |
dc.description.abstract | 1.The metabolites of fimasartan (FMS), a new angiotensin II receptor antagonist, were characterized in human liver microsomes (HLM) and human subjects.2.We developed a method for a simultaneous quantitative and qualitative analysis using predictive multiple reaction monitoring information-dependent acquisition-enhanced product ion scanning. To characterize metabolic reactions, FMS metabolites were analyzed using quadrupole-time of flight mass spectrometer in full-scan mode.3.The structures of metabolites were confirmed by comparison of chromatographic retention times and mass spectra with those of authentic metabolite standards.4.In the cofactor-dependent microsomal metabolism study, the half-lives of FMS were 56.7, 247.9 and 53.3min in the presence of NADPH, UDPGA and NADPH+UDPGA, respectively.5.The main metabolic routes in HLM were S-oxidation, oxidative desulfuration, n-butyl hydroxylation and N-glucuronidation.6.In humans orally administered with 120mg FMS daily for 7 days, the prominent metabolites were FMS S-oxide and FMS N-glucuronide in the 0-8-h pooled plasma sample of each subject.7.This study characterizes, for the first time, the metabolites of FMS in humans to provide information for its safe use in clinical medicine. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | TAYLOR & FRANCIS LTD | - |
dc.subject | LINEAR ION-TRAP | - |
dc.subject | II RECEPTOR ANTAGONIST | - |
dc.subject | IN-VITRO METABOLISM | - |
dc.subject | TRIPLE QUADRUPOLE | - |
dc.subject | MASS-SPECTROMETER | - |
dc.subject | DRUG-INTERACTIONS | - |
dc.subject | PHARMACOKINETICS | - |
dc.subject | IDENTIFICATION | - |
dc.subject | STABILITY | - |
dc.subject | DISCOVERY | - |
dc.title | Characterization of fimasartan metabolites in human liver microsomes and human plasma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Ki Ho | - |
dc.identifier.doi | 10.3109/00498254.2015.1047429 | - |
dc.identifier.scopusid | 2-s2.0-84954441630 | - |
dc.identifier.wosid | 000368026300005 | - |
dc.identifier.bibliographicCitation | XENOBIOTICA, v.46, no.1, pp.40 - 51 | - |
dc.relation.isPartOf | XENOBIOTICA | - |
dc.citation.title | XENOBIOTICA | - |
dc.citation.volume | 46 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 40 | - |
dc.citation.endPage | 51 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.subject.keywordPlus | LINEAR ION-TRAP | - |
dc.subject.keywordPlus | II RECEPTOR ANTAGONIST | - |
dc.subject.keywordPlus | IN-VITRO METABOLISM | - |
dc.subject.keywordPlus | TRIPLE QUADRUPOLE | - |
dc.subject.keywordPlus | MASS-SPECTROMETER | - |
dc.subject.keywordPlus | DRUG-INTERACTIONS | - |
dc.subject.keywordPlus | PHARMACOKINETICS | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.subject.keywordPlus | STABILITY | - |
dc.subject.keywordPlus | DISCOVERY | - |
dc.subject.keywordAuthor | Fimasartan | - |
dc.subject.keywordAuthor | metabolic stability | - |
dc.subject.keywordAuthor | metabolite identification | - |
dc.subject.keywordAuthor | qualitative and quantitative analysis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.